Literature DB >> 26710826

Development and optimization of a new processing approach for manufacturing topical liposomes-in-hydrogel drug formulations by dual asymmetric centrifugation.

Sveinung G Ingebrigtsen1, Nataša Škalko-Basnet1, Ann Mari Holsæter1.   

Abstract

OBJECTIVE: The objective of the present study was to utilize dual asymmetric centrifugation (DAC) as a novel processing approach for the production of liposomes-in-hydrogel formulations.
MATERIALS AND METHODS: Lipid films of phosphatidylcholine, with and without chloramphenicol (CAM), were hydrated and homogenized by DAC to produce liposomes in the form of vesicular phospholipid gels with a diameter in the size range of 200-300 nm suitable for drug delivery to the skin. Different homogenization processing parameters were investigated along with the effect of adding propylene glycol (PG) to the formulations prior to homogenization. The produced liposomes were incorporated into a hydrogel made of 2.5% (v/v) soluble β-1,3/1,6-glucan (SBG) and mixed by DAC to achieve a homogenous liposomes-in-hydrogel-formulation suitable for topical application. RESULTS AND DISCUSSION: CAM-containing liposomes with a vesicle diameter of 282 ± 30 nm and polydispersity index (PI) of 0.13 ± 0.02 were successfully produced by DAC after 50 min centrifugation at 3500 rpm, and homogenously (< 4% content variation) incorporated into the SBG hydrogel. Addition of PG decreased the necessary centrifugation time to 2 min and 55 s, producing liposomes of 230 ± 51 nm and PI of 0.25 ± 0.04. All formulations had an entrapment efficiency of approximately 50%.
CONCLUSION: We managed to develop a relatively fast and reproducible new method for the production of liposomes-in-hydrogel formulations by DAC.

Entities:  

Keywords:  Chloramphenicol; dual asymmetric centrifugation; hydrogels; liposomes; skin therapy; soluble beta-glucan

Mesh:

Substances:

Year:  2016        PMID: 26710826     DOI: 10.3109/03639045.2015.1135940

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  4 in total

1.  The stress regulator FKBP51: a novel and promising druggable target for the treatment of persistent pain states across sexes.

Authors:  Maria Maiarù; Oakley B Morgan; Tianqi Mao; Michaela Breitsamer; Harry Bamber; Max Pöhlmann; Mathias V Schmidt; Gerhard Winter; Felix Hausch; Sandrine M Géranton
Journal:  Pain       Date:  2018-07       Impact factor: 7.926

2.  Comparative study of free and liposome-entrapped chloramphenicol against biofilms of potentially pathogenic bacteria isolated from cooling towers.

Authors:  Marcus Vinícius Dias-Souza; Daniel Lucas Soares; Vera Lúcia Dos Santos
Journal:  Saudi Pharm J       Date:  2017-03-12       Impact factor: 4.330

3.  Dual Asymmetric Centrifugation Efficiently Produces a Poloxamer-Based Nanoemulsion Gel for Topical Delivery of Pirfenidone.

Authors:  Eugene P Chung; Adrienne R Wells; Mia Mae Kiamco; Kai P Leung
Journal:  AAPS PharmSciTech       Date:  2020-10-02       Impact factor: 3.246

4.  Screening for Optimal Liposome Preparation Conditions by Using Dual Centrifugation and Time-Resolved Fluorescence Measurements.

Authors:  Jonas K Koehler; Johannes Schnur; Heiko Heerklotz; Ulrich Massing
Journal:  Pharmaceutics       Date:  2021-11-30       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.